Abstract
(Pregnancy Hypertens. 2018;11:77–80. Doi:10.1016/j.preghy.2018.01.002) The management of chronic hypertension, which affects ~5% of all US pregnancies, requires careful balance. While many drugs used to treat hypertension have been well-studied, there is a lack of options that have been adequately studied during pregnancy and lactation. Amlodipine is an ideal option for use in pregnancy due to its long half-life, infrequent dosing, low cost and positive side-effect profile, but more data are needed on its use in pregnant and lactating patients and whether it crosses the placenta. This study aimed to evaluate the pharmacokinetics of amlodipine besylate in a population of pregnant women during delivery and postpartum lactation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
